GeneLink, Inc.
GNLKQ
$0.00
$0.000.00%
| 09/30/2013 | 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | |
|---|---|---|---|---|---|
| Revenue | 1.73M | 1.86M | 1.76M | 2.14M | 2.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.73M | 1.86M | 1.76M | 2.14M | 2.61M |
| Cost of Revenue | 1.27M | 1.57M | 1.64M | 1.67M | 1.57M |
| Gross Profit | 456.50K | 294.30K | 123.70K | 464.80K | 1.03M |
| SG&A Expenses | 2.28M | 2.37M | 2.68M | 3.44M | 4.54M |
| Depreciation & Amortization | 57.00K | 50.50K | 59.40K | 69.10K | 82.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.78M | 4.20M | 4.63M | 5.43M | 6.42M |
| Operating Income | -2.05M | -2.34M | -2.87M | -3.30M | -3.82M |
| Income Before Tax | -2.23M | -2.66M | -3.30M | -3.05M | -3.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.23 | -2.66 | -3.30 | -3.05 | -3.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.23M | -2.66M | -3.30M | -3.05M | -3.48M |
| EBIT | -2.05M | -2.34M | -2.87M | -3.30M | -3.82M |
| EBITDA | -1.96M | -2.24M | -2.76M | -3.19M | -3.71M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.02B | 968.36M | 913.49M | 865.08M | 822.77M |
| Average Diluted Shares Outstanding | 1.02B | 968.36M | 913.49M | 865.08M | 822.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
